Drug Information

Drug General Information
Drug ID
D09SIR
Former ID
DCL000153
Drug Name
Lonidamine
Synonyms
DICA; Doridamina; Lonidamin; Lonidamina; Lonidaminum; Dichlondazolic acid; Diclondazolic acid; AF 1890; L 4900; AF-1890; Doridamina (TN); KN-228; Lonidamina [INN-Spanish]; Lonidamine (INN); Lonidamine [BAN:INN]; Lonidaminum [INN-Latin]; TH-070; 1-(2,4-Dichlorbenzyl)-indazole-3-carboxylic acid; 1-(2,4-Dichlorobenzyl)-1H-indazole-3-carboxylic acid; 1-(2,4-dichlorobenzyl)indazole-3-carboxylic acid; 1-[(2,4-dichlorophenyl)methyl]-1H-indazole-3-carboxylic acid; 1-[(2,4-dichlorophenyl)methyl]indazole-3-carboxylic acid; 1H-Indazole-3-carboxylic acid, 1-((2,4-dichlorophenyl)methyl)-(9CI)
Drug Type
Small molecular drug
Indication Benign Prostatic hyperplasia; Prostate disorders [ICD9: 600; ICD10:N40] Discontinued in Phase 3 [548113]
Company
Threshold Pharma
Structure
Download
2D MOL

3D MOL
Formula
C15H10Cl2N2O2
Canonical SMILES
C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O
InChI
1S/C15H10Cl2N2O2/c16-10-6-5-9(12(17)7-10)8-19-13-4-2-1-3-11(13)14(18-19)15(20)21/h1-7H,8H2,(H,20,21)
InChIKey
WDRYRZXSPDWGEB-UHFFFAOYSA-N
CAS Number
CAS 50264-69-2
PubChem Compound ID
39562
PubChem Substance ID
6136961, 8176094, 11111381, 11114165, 11532966, 12012701, 14850521, 17405279, 24278515, 34705437, 47869651, 48413946, 49836722, 49857453, 50104921, 50104922, 51091595, 53777824, 53789939, 56311866, 57312316, 74608688, 80954275, 85231114, 85789040, 90341155, 91146217, 91720576, 92304137, 92716386, 104332053, 118311205, 121361741, 123093828, 124749939, 124800868, 124880555, 124880556, 124880557, 124880558, 124880559, 125351545, 126622913, 126654428, 126662083, 129566730, 134338833, 135001654, 135684247, 135692553
ChEBI ID
ChEBI:50138
SuperDrug ATC ID
L01XX07
SuperDrug CAS ID
cas=050264692
References
Ref 548113Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800022059)

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.